A Proteomics- and Metabolomics-Based Study Revealed That Disorder of Palmitic Acid Metabolism by Aconitine Induces Cardiac Injury.
暂无分享,去创建一个
Pengjie Zhang | Yubo Li | Yuming Wang | Yanyan Xu | Yanjun Zhang | Simiao Fan | Chenghao Bi | Yuecheng Liu | Huan Zhao | Ya-ming Li | Tianpu Zhang | Kun Gu | Wulin Qi | Jiao Yu
[1] Hong Wu,et al. Taurine–magnesium coordination compound, a potential anti‐arrhythmic complex, improves aconitine‐induced arrhythmias through regulation of multiple ion channels , 2018, Toxicology and applied pharmacology.
[2] K. Magalhães,et al. Omega-3 docosahexaenoic acid induces pyroptosis cell death in triple-negative breast cancer cells , 2018, Scientific Reports.
[3] L. O’Neill,et al. Metabolic regulation of NLRP3 , 2018, Immunological reviews.
[4] Yue-jin Yang,et al. Investigation of novel metabolites potentially involved in the pathogenesis of coronary heart disease using a UHPLC-QTOF/MS-based metabolomics approach , 2017, Scientific Reports.
[5] J. C. Ralston,et al. Fatty Acids and NLRP3 Inflammasome-Mediated Inflammation in Metabolic Tissues. , 2017, Annual review of nutrition.
[6] Chunze Zhang,et al. Role of the lipid-regulated NF-κB/IL-6/STAT3 axis in alpha-naphthyl isothiocyanate-induced liver injury , 2016, Archives of Toxicology.
[7] M. Farag,et al. A Comparative Metabolomics Approach Reveals Early Biomarkers for Metabolic Response to Acute Myocardial Infarction , 2016, Scientific Reports.
[8] Tom R. Gaunt,et al. A Protein Domain and Family Based Approach to Rare Variant Association Analysis , 2016, PloS one.
[9] Xueping Zhou,et al. Development and application of a comprehensive lipidomic analysis to investigate Tripterygium wilfordii-induced liver injury , 2016, Analytical and Bioanalytical Chemistry.
[10] Gui-Bo Sun,et al. Aconitine-induced Ca2+ overload causes arrhythmia and triggers apoptosis through p38 MAPK signaling pathway in rats. , 2014, Toxicology and applied pharmacology.
[11] J. Kalbfleisch,et al. MicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6. , 2014, Cardiovascular research.
[12] Amir Lerman,et al. Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicity. , 2013, Pharmacology & therapeutics.
[13] Juan Zhou,et al. The exposure of highly toxic aconitine does not significantly impact the activity and expression of cytochrome P450 3A in rats determined by a novel ultra performance liquid chromatography-tandem mass spectrometric method of a specific probe buspirone. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[14] T. Keller,et al. Fatal aconitine intoxication or thyroid storm? A case report. , 2012, Legal medicine.
[15] L. Tian,et al. Functional characterization of the p53 binding site in the human PYNOD promoter. , 2012, Human immunology.
[16] Xin Fu,et al. Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysis , 2012, Medical Oncology.
[17] M. Abreu,et al. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders. , 2009, Seminars in immunology.
[18] K. Thornburg,et al. Sarcoplasmic reticulum Ca2+ release channel ryanodine receptor (RyR2) plays a crucial role in aconitine-induced arrhythmias. , 2008, Biochemical pharmacology.
[19] Katsuo Takahashi,et al. Five cases of aconite poisoning: toxicokinetics of aconitines. , 2007, Journal of analytical toxicology.
[20] Zhao Wang,et al. Disruption of the intracellular Ca2+ homeostasis in the cardiac excitation-contraction coupling is a crucial mechanism of arrhythmic toxicity in aconitine-induced cardiomyocytes. , 2007, Biochemical and biophysical research communications.
[21] Md. Shah Amran,et al. Effects of Sodium-Calcium Exchange Inhibitors, KB-R7943 and SEA0400, on Aconitine-Induced Arrhythmias in Guinea Pigs in Vivo, in Vitro, and in Computer Simulation Studies , 2004, Journal of Pharmacology and Experimental Therapeutics.
[22] C. Guillemette. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes , 2003, The Pharmacogenomics Journal.